Evidence map›Paper›PMID 41507313›Full record

ArticleScientific reports2026

Suspension cultivation of mosquito cell lines for the production of the mosquito-borne flavivirus Usutu virus in a stirred-tank bioreactor.

Dennis Kenbeek, Joshua Kanters, Karim Bousnina, Mels Schrama, Dirk E Martens, Jelke J Fros

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Dennis KenbeekLaboratory of Virology, Wageningen University and Research, Wageningen, The Netherlands.
Joshua KantersLaboratory of Virology, Wageningen University and Research, Wageningen, The Netherlands.
Karim BousninaLaboratory of Virology, Wageningen University and Research, Wageningen, The Netherlands.
Mels SchramaBioprocess Engineering, Wageningen University and Research, Wageningen, The Netherlands.
Dirk E MartensBioprocess Engineering, Wageningen University and Research, Wageningen, The Netherlands.
Jelke J FrosLaboratory of Virology, Wageningen University and Research, Wageningen, The Netherlands. jelke.fros@wur.nl.

Funding

Nederlandse Organisatie voor Wetenschappelijk Onderzoek VI. Vidi. 213.027
6 · The paper itself

Abstract

Mosquito-borne pathogens are a global health burden. The realization of a scalable serum-free mosquito cell suspension cultivation method would enable the production of novel biotechnological products, including vaccines, recombinant proteins, and (modified) viruses for biological control. This study reports the adaptation of two Aedes-derived cell lines, C6/36 and U4.4, to serum-free suspension conditions using the chemically defined EX-CELL medium. Both cell lines achieved high cell concentrations (> 1.0 × 107 cells/mL) in shake flasks with minimal adaptation. The C6/36 suspension cultures were subsequently transferred to a 500 mL stirred tank bioreactor (STR), which likewise achieved high cell concentrations (1.3 × 107 cells/mL) and a doubling time of 31–36 h. As a proof of concept for the production of a virus in this system, C6/36 cells were cultivated in a STR and infected with the mosquito-borne flavivirus Usutu virus (USUV). These cultures produced high virus titers (> 3.6 × 108 TCID50/mL), with similar growth kinetics compared to adherent and shake flask cultures. This work is the first to show C6/36 mosquito cell cultivation in a bioreactor and demonstrates the potential of this serum-free suspension culture system for the efficient production of mosquito-infecting viruses.

Indexed as

AedesBioreactorsCell Culture TechniquesFlavivirusVirus CultivationAnimalsCell Line

Identifiers

PMID41507313
PMCPMC12852204

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.